Patents by Inventor Robert W. Vertri

Robert W. Vertri has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Biomarkers and targets for diagnosis, prognosis and management of prostate disease
    Publication number: 20010007748
    Abstract: Disclosed are diagnostic techniques for the detection of human prostate disease. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in metastatic prostate cancer compared to normal human prostate, benign prostatic hyperplasia, and non-metastatic prostate cancer. The invention also relates to probes and methods for evaluating the presence of RNA species that are differentially expressed in the peripheral blood of individuals with the disease state compared to normal healthy individuals. Described are methods of therapeutic use for genes identified as differentially expressed in metastatic prostate cancer, and means for screening pharmaceuticals effective in treatment of prostate cancer.
    Type: Application
    Filed: January 9, 2001
    Publication date: July 12, 2001
    Inventors: Gang An, Robert W. Vertri
  • Biomarkers and targets for diagnosis prognosis and management of prostate disease
    Patent number: 6171796
    Abstract: Disclosed are diagnostic techniques for the detection of human prostate disease. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in metastatic prostate cancer compared to normal human prostate, benign prostatic hyperplasia, and non-metastatic prostate cancer. The invention also relates to probes and methods for evaluating the presence of RNA species that are differentially expressed in the peripheral blood of individuals with the disease state compared to normal healthy individuals. Described are methods of therapeutic use for genes identified as differentially expressed in metastatic prostate cancer, and means for screening pharmaceuticals effective in treatment of prostate cancer.
    Type: Grant
    Filed: August 3, 1999
    Date of Patent: January 9, 2001
    Assignee: Urocor, Inc.
    Inventors: Gang An, Robert W. Vertri
  • Biomarkers and targets for diagnosis, prognosis and management of prostate disease
    Patent number: 5972615
    Abstract: Disclosed are diagnostic techniques for the detection of human prostate disease. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in metastatic prostate cancer compared to normal human prostate, benign prostatic hyperplasia, and non-metastatic prostate cancer. The invention also relates to probes and methods for evaluating the presence of RNA species that are differentially expressed in the peripheral blood of individuals with the disease state compared to normal healthy individuals. Described are methods of therapeutic use for genes identified as differentially expressed in metastatic prostate cancer, and means for screening pharmaceuticals effective in treatment of prostate cancer.
    Type: Grant
    Filed: January 21, 1998
    Date of Patent: October 26, 1999
    Assignee: Urocor, Inc.
    Inventors: Gang An, Robert W. Vertri